Researchers have found that triple-negative breast cancer cells can resist being killed by natural killer cells through a mechanism involving interleukin-11 trans-signaling. Studies are exploring ways to overcome this resistance, including combining different treatments to enhance the susceptibility of breast cancer cells to natural killer cell-mediated killing. The exact mechanisms of immune evasion in triple-negative breast cancer and potential therapeutic approaches are being investigated in various research efforts.